IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BPTH

Balance Sheet

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.010.000.000.121.170.564.010.191.052.353.446.7310.3813.6517.0221.2523.7726.6028.0930.79
Total Current Assets0.680.660.682.123.782.905.021.643.044.806.2610.7915.6218.1420.5623.6126.1430.2330.6432.62
Property, Plant & Equipment----0.010.020.020.040.050.050.080.090.110.140.160.180.200.200.230.220.240.21
Total Non-current Assets*0.000.030.070.080.110.070.100.130.180.220.270.310.360.400.450.470.430.450.490.48
Total Assets0.680.690.752.193.882.975.121.773.225.026.5211.1015.9718.5421.0124.0826.5730.6831.1333.10
Accounts Payable5.164.903.482.441.271.040.771.750.460.280.640.830.671.050.610.410.110.420.510.39
Total Current Liabilities9.158.687.864.743.303.383.013.811.911.361.431.911.682.201.321.570.961.161.181.52
Total Non-current Liabilities*0.010.010.040.040.430.300.820.580.871.140.060.090.110.140.170.200.150.170.190.21
Total Liabilities9.168.697.904.783.733.683.834.392.782.501.482.001.802.341.491.761.111.331.371.73
Retained Earnings(126.44)(125.93)(124.95)(120.35)(117.50)(114.75)(112.63)(110.76)(107.61)(104.23)(101.04)(96.80)(91.53)(87.56)(84.03)(81.02)(77.66)(73.54)(71.48)(69.67)
Total Stockholder Equity(8.49)(8.00)(7.16)(2.59)0.15(0.71)1.29(2.62)0.442.535.049.1114.1716.2019.5222.3225.4629.3529.7531.37
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Research & Development0.040.284.051.981.821.321.872.292.282.293.053.992.862.351.852.102.910.980.761.26
Selling, General & Admin0.260.210.511.260.811.321.171.410.760.981.191.301.121.191.161.261.211.091.051.19
Total Operating Expenses0.300.494.563.242.632.633.043.703.033.284.245.293.993.553.013.364.122.071.812.45
Operating Income(0.30)(0.49)(4.56)(3.24)(2.62)(2.63)(3.04)(3.69)(3.03)(3.28)(4.24)(5.29)(3.99)(3.55)(3.01)(3.36)(4.12)(2.07)(1.81)(2.45)
Net Income(0.27)(0.98)(4.60)(2.85)(2.75)(2.12)(1.87)(3.16)(3.37)(3.20)(4.23)(5.27)(3.97)(3.53)(3.01)(3.36)(4.12)(2.07)(1.81)(2.45)
Basic EPS----(0.55)(0.40)2.62(0.70)(1.16)(4.88)(32.12)(0.32)(0.53)(0.66)(0.53)(0.49)(0.42)(0.47)(0.57)------
Diluted EPS(0.03)(0.11)(0.55)(0.40)2.62(0.70)(1.16)(4.88)(32.12)(0.32)(0.53)(0.66)(0.53)(0.49)(0.42)(0.47)(0.57)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow(0.04)0.00(0.28)(1.31)(2.88)(7.69)(4.27)(1.04)(1.81)(2.78)(3.29)(3.65)(5.00)(3.37)(4.20)(2.53)(2.80)(2.89)(2.65)(1.57)
Capital Expenditures------------------------0.000.000.02--0.020.000.05--
Free Cash Flow*------------------------(5.00)(3.37)(4.22)--(2.82)(2.89)(2.70)--
Investing Cash Flow------------------------0.000.00(0.02)--(0.02)0.00(0.05)--
Financing Cash Flow0.050.000.160.263.497.207.220.170.511.69-------------0.001.400.0018.61
← Scroll for more columns →

* Derived from reported values